FDA CDER Impact Story: Helping to Better Communicate the Risks and Benefits in Prescription Drug Advertising – Drug Information Update

FDA CDER Impact Story: Helping to Better Communicate the Risks and Benefits in Prescription Drug Advertising – Drug Information Update 

Direct-to-consumer advertising can influence awareness of prescription drug treatments, which can in turn influence which prescription drugs patients seek out and doctors prescribe. Using eye-tracking technology, researchers are examining elements of these ads that can affect the viewer’s ability to understand the risks and benefits of a drug. The goal of this research is to help drug companies develop ads that better inform the public.

To learn more, please visit: FDA CDER Impact Story.